JANE MBITHE MUINDE

Dr. JANE MBITHE MUINDE


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 November 2025 in Diseases
Verified
Journal Article
Open access
PDF file
JMJANE MBITHE MUINDE
JANE MBITHE MUINDE
CYCelina Romi Yamauchi
Celina Romi Yamauchi
JCJoseph Cruz
Joseph Cruz
AMAlena Analeigh McQuarter
Alena Analeigh McQuarter
KMKyah Miller
Kyah Miller
SKSalma Khan
Salma Khan
Background: Ovarian cancer (OC) is the second most common gynecologic malignancy in the United States and remains the leading cause of death among cancers of the female reproductive system. Alarmingly, mortality rates have risen disproportionately among women of African ancestry compared to those of European or Asian descent. Identifying microRNA (miRNA) signatures that contribute to these disparities may enhance prognostic accuracy and inform personalized therapeutic strategies. Methods: In this study, we identified prognostic markers of overall survival in serous ovarian cancer (SOC) using data from The Cancer Genome Atlas (TCGA) and the Human Protein Atlas. Integrative bioinformatic analyses revealed three key prognostic genes—TIMP3 (Tissue Inhibitor of Metalloproteinases-3), BRAF (v-raf murine sarcoma viral oncogene homolog B), and ITGB1 (Integrin Beta-1)—as critical molecular determinants associated with survival in patients with SOC. Candidate miRNAs regulating these genes were predicted using TargetScanHuman v8.0, identifying a core regulatory set comprising miR-192, miR-30d, miR-16-5p, miR-143-3p, and miR-20a-5p. To validate their clinical relevance, formalin-fixed, paraffin-embedded (FFPE) and fresh SOC tumor samples were obtained from African American and Caucasian patients who underwent surgery at Loma Linda University (LLU) between 2010 and 2023. Results and Discussion: Among all these, ITGB1 (p = 0.00033), TIMP3 (p = 0.0035), and BRAF (p = 0.026) emerged as statistically significant predictors. Following total RNA extraction, cDNA synthesis, and quantitative reverse transcription PCR (qRT-PCR), the expression levels of these miRNAs and their target genes were quantified. In the LLU cohort, ITGB1 and TIMP3 were significantly upregulated in African American patients compared to Caucasian patients (p < 0.01 and p < 0.02, respectively). Among the miRNAs, miR-192-5p was particularly noteworthy, showing marginally differential expression in LLU samples (p = 0.0712) but strong statistical significance in the TCGA cohort (p = 0.00013), where elevated expression correlated with poorer overall survival (p = 0.021). Pathway enrichment and gene ontology analyses (miRTargetLink2.0, Enrichr) revealed interconnected regulatory networks linking miR-192, miR-16-5p, miR-143-3p, and miR-20a-5p to ITGB1; miR-143-3p/miR-145-5p to BRAF; and miR-16-5p and miR-30c/d to TIMP3. Conclusions: Collectively, these findings identify distinct miRNA–mRNA regulatory signatures—particularly the miR-192-5p–ITGB1/TIMP3 axis—as potential clinically relevant biomarkers that may contribute to racial disparities and disease progression in ovarian cancer.

20 February 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
JMJANE MBITHE MUINDE
JANE MBITHE MUINDE
DCDan Kerry Celestin
Dan Kerry Celestin
JCJoseph Cruz
Joseph Cruz
USUmang Sharma
Umang Sharma
IMInnocent O Maranga
Innocent O Maranga
SKSalma Khan
Salma Khan
High-Grade Serous Ovarian Carcinoma (HGSOC) is a highly heterogeneous disease. Machine learning-based cellular morphometric biomarkers (CMB-ML) have been identified across multiple tumor types, capturing tissue heterogeneity, predicting tumor microenvironments (TME) and clinical outcomes. We aimed to identify ethnicity-specific CMBs in African American and White HGSOC patients using whole-slide images (WSIs) and assess their associations with overall survival (OS). Analysis of 109 patients from The Cancer Genome Atlas Ovarian Cancer (TCGA-OV) cohort was validated in WSIs from 22 patients in the Loma Linda University (LLU) cohort. We linked immune checkpoint markers (ICM) to CMB scores and confirmed via immunohistochemistry. We identified and validated three ethnicity-specific CMBs — 73, 80, and 215 with significant frequency differences. Higher CMB 73 and 80 frequencies correlated with shorter OS in African Americans (p=0.022, p=0.023), while higher CMB 215 frequency was linked to improved OS in White patients (p=0.051). Molecular analysis of TCGA-OV cohort revealed lower immune infiltration in African Americans and higher ICM expression in Whites (PDCD1: p=0.033, PDCD1LG2: p=0.014, CD8A: p=0.014). Immunohistochemistry in the LLU-OV cohort showed expression of predicted markers CD3, CD8, and PDCD1. Although there were no significant differences between the two ethnic groups, CMB-ML explores a new avenue for understanding health disparities.

30 April 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
JMJANE MBITHE MUINDE
JANE MBITHE MUINDE
CYCelina Romi Yamauchi
Celina Romi Yamauchi
USUmang Sharma
Umang Sharma
SSSkyler Schiff
Skyler Schiff
IKIsaac Jacob Kremsky
Isaac Jacob Kremsky
SKSalma Khan
Salma Khan
Ovarian cancer (OC) is the second most common gynecologic malignancy in the U.S. and the leading cause of death among cancers of the female reproductive system. Notably, mortality rates have disproportionately increased among women of African ancestry compared to those of Asian or European descent. Identifying microRNA (miRNA) signatures linked to these racial disparities may improve prognostic tools and guide personalized treatment. In this study, we first identified key prognostic markers for overall survival in serous ovarian cancer (SOC) from TCGA via the Human Protein Atlas, including ITGB1 (p=0.00033), TIMP3 (p=0.0035), and BRAF (p=0.026). Using TargetScanHuman v8.0, we predicted miRNAs targeting these genes and selected those commonly associated: miR-192, miR-30d, hsa-miR-16-5p, miR-143-3p, and miR-20a-5p. Formalin-fixed, paraffin-embedded (FFPE), and fresh SOC tissue samples from African American and Caucasian patients were collected post-surgery at Loma Linda University (2010–2023). Total RNA was extracted, followed by cDNA synthesis and qRT-PCR to assess miRNA expression. Expression data from LLU were then correlated with clinicopathologic data from TCGA (n=445). miR-192-5p emerged as the most significant, showing marginal differential expression in LLU samples (p=0.0712) and a significant correlation with survival in TCGA (p=0.021). Further pathway enrichment and gene ontology analyses using miRTargetLink2.0 and Enrichr linked miR-192, miR-16-5p, miR-143-3p, and miR-20a-5p to ITGB1; miR-143-3p/miR-145-5p to BRAF; and miR-16-5p and miR-30c/d to TIMP3. These findings suggest miRNA signatures, particularly miR-192-5p, may have clinical relevance in addressing racial disparities in OC prognosis and therapy.